Patheon 1Q11 1Q Revenues: $175.7 million (+12%) 1Q Loss: $500,000 (loss of $11.1 million 1Q10) Comments: Commercial manufacturing revenues were up 16% to $148.7 million. North American commercial revenues were $5.1 million (+9%). European commercial revenues were $15.5 million (+22%). Pharmaceutical Development Services revenues were $27.0 million (+1%). European commercial revenues benefited from a $30 million reservation payout by a client that chose not to continue a lyophilized ce...